Astrazeneca Pharma Peer Comparison

NSE: ASTRAZEN | BSE: 506820

₹6,133.50

up-down-arrow ₹-34.50 (-0.56%)

As on 18-Nov-2026 14:14IST

Market cap

info icon

₹15,628 Cr

Revenue (TTM)

info icon

₹2,602 Cr

P/E Ratio

info icon

87.9

P/B Ratio

info icon

17.8

Div. Yield

info icon

0.6 %

Edit peer-selector-edit
Astrazeneca Pharma Shilpa Medicare Eris Lifesciences Caplin Point Lab Pfizer
Market cap (₹ Cr)
15,628 18,172 18,911 15,875 17,389
Revenue (₹ Cr)
2,602 1,842 3,330 2,383 2,654
Net Profit (₹ Cr)
177.73 308.62 720.77 700.18 859.38
Net Margin (%)
6.74 16.63 21.60 27.87 30.42
RoE (%)
21.49 11.81 18.93 18.40 18.58
Price to Earnings
87.93 54.66 26.73 23.04 20.23
Price-To-Book
17.78 6.59 4.56 4.07 3.97

Income Statement (₹ Cr)

Liabilities (₹ Cr)

Assets (₹ Cr)

Cashflow (₹ Cr)

Ratios

Profitability Ratios

Growth Ratios

Valuation Ratios

Solvency Ratios

Operating Efficiency Ratios

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month